According to SNS Insider, the global RNAi Technology Market was valued at USD 3.02 billion in 2024 and is projected to reach USD 9.03 billion by 2032, expanding at a CAGR of 14.68% over 2025–2032. RNA ...

Researchers from the University of Eastern Finland and Aalto University have developed a computational framework called ...

An update from Veritas In Silico Inc. ( ($JP:130A) ) is now available. Veritas In Silico Inc. and Dexerials Corporation have announced a joint ...

Learn how advanced molecular dynamics simulations can improve RNA-based therapeutics by modeling complex folding processes.

Researchers at the University of Bonn have uncovered how a kidney RNA molecule can trigger autoimmune disease. In mice, a ...

The RNA Institute at the University at Albany is getting a $50 million expansion to help bring more discoveries to market.

Victorian researchers have developed a world-first RNA drug to prevent the damaging effects of lupus, marking a breakthrough ...

Seattle's Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a $225 million ...

Discover key Q3 2025 earnings insights for Maravai LifeSciences. Learn about revenue trends, cost reductions, and growth outlook.

Researchers fhave created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain cancer cells survive.

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The ...